Target intelligence / Profile preview

Centrosomal protein of 162 kDa (CEP162)

Target
CEP162
Molecular classification
Other (centrosomal protein), Microtubule-associated protein
01

Overview

Centrosomal protein of 162 kDa (CEP162) is a centrosome- and microtubule-associated protein essential for the assembly of the ciliary transition zone (TZ), a key region at the base of cilia that regulates compartmentalization and signaling[1][2]. CEP162 is "pre-tethered" at centriole distal ends prior to ciliogenesis, where it directly binds to axonemal microtubules through its coiled-coil domains and promotes the recruitment of core transition zone components (e.g., CEP290, NPHP1, Tctn2)[1]. Loss of CEP162 disrupts TZ assembly and arrests ciliogenesis, resulting in cellular and tissue defects. In the retina, biallelic truncating mutations in CEP162 impair ciliary function specifically in photoreceptors, leading to late-onset retinitis pigmentosa, while maintaining partial neuronal differentiation functions[2]. CEP162 is not currently considered a direct therapeutic target, and no drugs are known to interact with it. Its primary biomedical relevance is as a causative gene for certain retinal ciliopathies and as a biomarker for associated inherited retinopathies[2].

Other names
Centrosomal protein 162CEP162C6orf84KIAA1009QN1protein QN1 homologcentrosomal protein 162kDa
02

Biological functions

Ciliogenesis (assembly and maintenance of the ciliary transition zone)Microtubule bindingPromotion of transition zone (TZ) assembly at cilia baseNeuronal differentiation in the retina
03

Disease associations

Retinal degeneration (including retinitis pigmentosa)Ciliopathy (disorders arising from cilia dysfunction)Neurodevelopment (implicated in neuronal survival in the retina)
04

Biomarkers

Genetic variants (frameshift/truncating mutations in CEP162 gene observed in retinitis pigmentosa patients)

Beyond the preview

Go deeper on Centrosomal protein of 162 kDa (CEP162).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrosomal protein of 162 kDa (CEP162).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call